RCEL Live-Signale | Maximieren Sie Profite mit Getagraph.com

VERKAUFEN 109558 min ago

@ $17.14

Ausgestellt: 13 Feb 2024 @ 21:41

Rendite: -49.12%

Vorheriges Signal: Feb 12 - 19:54

Vorheriges Signal: Kaufen

Rendite: 0.06 %

Live Chart Being Loaded With Signals

Commentary (29 Apr 2024 @ 22:00):

Stats
Tagesvolumen	185 653
Durchschnittsvolumen	236 190
Marktkapitalisierung	224.97M
EPS	$0 ( 2024-02-22 )
Nächstes Ertragsdatum	( $-0.260 ) 2024-05-13
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-6.23
ATR14	$0.0160 (0.18%)

Insider Trading

Date	Person	Action	Amount	type
2024-02-28	O'toole David D	Buy	250	Common Stock
2024-02-28	O'toole David D	Buy	1 000	Common Stock
2024-01-03	Shiroma Donna	Buy	100 000	Stock Options (Right to Buy)
2023-11-30	Shiroma Donna	Buy	1 469	Common Stock
2024-01-03	O'toole David D	Buy	125 000	Stock Options (Right to Buy)

INSIDER POWER
72.68
Last 97 transactions
Buy: 1 597 984 \| Sell: 352 272

Volumen Korrelation

Lang: 0.30 (neutral)

Kurz: -0.51 (weak negative)

Signal:(61.745) Neutral

Avita Therapeutics Inc Korrelation

10 Am meisten positiv korreliert
LWAC	0.956
NSIT	0.948
SJ	0.935
SRAC	0.93
MCAA	0.929
AMRB	0.929
TZPS	0.927
USAP	0.924
COCO	0.923
BIOT	0.922

10 Am meisten negativ korreliert
SVAC	-0.949
FRBK	-0.94
AROW	-0.937
BCBP	-0.93
BWB	-0.926
GSMG	-0.921
DSWL	-0.92
ESPR	-0.919
VGFC	-0.918
FVCB	-0.917

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

Avita Therapeutics Inc Korrelation - Währung/Rohstoff

0.48
( neutral )

0.37
( neutral )

0.00
( neutral )

0.37
( neutral )

0.58
( weak )

-0.17
( neutral )

Avita Therapeutics Inc Finanzdaten

Annual	2022
Umsatz:	$34.42M
Bruttogewinn:	$28.38M (82.45 %)
EPS:	$-1.070

FY	2022
Umsatz:	$34.42M
Bruttogewinn:	$28.38M (82.45 %)
EPS:	$-1.070

FY	2021
Umsatz:	$29.23M
Bruttogewinn:	$23.28M (79.65 %)
EPS:	$-1.170

FY	2020
Umsatz:	$14.26M
Bruttogewinn:	$11.29M (79.16 %)
EPS:	$-2.07

Financial Reports:

No articles found.

Avita Therapeutics Inc

AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and proprietary platform technology provides treatment solutions derived from the regenerative properties of a patient's own skin. Its lead product is RECELL System, a device that enables healthcare professionals to produce a suspension of Spray-On Skin cells using a small sample of the patient's own skin for use in the treatment of acute thermal burns in patients eighteen years and older. The company has a research collaboration with the University of Colorado School of Medicine to establish pre-clinical proof-of-concept for a spray-on treatment of genetically corrected cells; and a research collaboration with Houston Methodist Research Institute to explore molecular reversal of cellular aging through a novel cell suspension delivery system. The company was formerly known as AVITA Therapeutics, Inc. and changed its name to AVITA Medical Inc. in December 2020. AVITA Medical Inc. was incorporated in 2000 and is based in Valencia, California.